Study ID: BDP-AR-101

Study Title

Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol

Teva Identifier

BDP-AR-101

ClinicalTrials.gov Identifier

NCT01537692

Study Status

Completed

Trial Condition(s)

Female, Maleergic Rhinitis

Interventions

Drug: BDP HFA Nasal Aerosol | Drug: BDP HFA Inhalation Aerosol (QVAR)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 45 Years

Trial Duration

03/01/2009 - 06/01/2009

Phase

Phase 1

Study Type

Interventional